Aspira Pathlab & Diagnostics Ltd
company logo

Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab Share Price

Healthcare
Small Cap

-

0 (0%)

Start Investing in Aspira Pathlab & Diagnostics Ltd

*By signing up you agree to our Terms and Conditions

Aspira Pathlab & Diagnostics Ltd Performance

-

-

-

-


-

-

-

-

-

Aspira Pathlab & Diagnostics Ltd Fundamentals

53.99Cr

0

10.36

0.16

0

0%

5.07

i buttonClick here to know more about Fundamentals

Aspira Pathlab & Diagnostics Ltd Financials

Aspira Pathlab & Diagnostics Ltd Financialsright-arrow

Aspira Pathlab & Diagnostics Ltd Shareholding Pattern

Aspira Pathlab & Diagnostics Ltd Delivery and Volume

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in

Pankaj Jashwant Shah

1973

-

NameDesignation
Pankaj Jashwant ShahManaging Director & CEO
Arvind Karsandas BhanushaliNon Executive Director
Mangala Radha Krishnan PrabhuIndependent Director
Haseeb DrabuChairman & Independent Directo
Nikunj MangeNon Executive Director
Subhash Raghunath SalunkeIndependent Director
A C MahajanIndependent Director
Manas MengarIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Aspira Pathlab & Diagnostics Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Aspira Pathlab & Diagnostics Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Aspira Pathlab & Diagnostics Ltd's share price is ₹52.45 as of 2024-10-30.
Aspira Pathlab & Diagnostics Ltd's P/E ratio is - times as of 2024-10-30.
Aspira Pathlab & Diagnostics Ltd's most recent financial reports indicate a price-to-book ratio of 10.36, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Aspira Pathlab & Diagnostics Ltd's market capitalization is ₹53.99 Cr as on 2024-10-30.
The current financial records of Aspira Pathlab & Diagnostics Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Aspira Pathlab & Diagnostics Ltd's most recent financial filings, the company has a total asset value of ₹4.36, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Aspira Pathlab & Diagnostics Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Aspira Pathlab & Diagnostics Ltd's 52-week high and low as of 2024-10-30 are ₹52.45 and ₹49.05, respectively.